[Increased resistance to hypoxia effected by the neuropeptide preparation SEMAX].
Kaplan
A Ia
AIa
Koshelev
V B
VB
Nezavibat'ko
V N
VN
Ashmarin
I P
IP
D000324:Adrenocorticotropic Hormone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D000818:Animals; D006801:Humans; D000860:Hypoxia / Q000276:immunology / Q000517:prevention & control*; D007113:Immunity, Innate / Q000187:drug effects; D008297:Male; D009479:Neuropeptides / Q000627:therapeutic use*; D010446:Peptide Fragments / Q000627:therapeutic use*; D051381:Rats; D017208:Rats, Wistar
D009479:Neuropeptides; D010446:Peptide Fragments; C048487:ACTH (4-7), Pro-Gly-Pro-; D000324:Adrenocorticotropic Hormone
Povyshenie ustoĭchivosti organizma k gipoksii s pomoshch'iu neĭropeptidnogo lekarstvennogo preparats SEMAKS.